[Table/Fig-5]:

Cumulative major adverse cardiac events at 30-days, 6-months and 9-months follow-up

Events	30-days follow-up (n=1008)	6-months follow-up (n=998)	9-months follow-up (n=998)
Death, n (%)	3 (0.30%)	4 (0.40%)	4 (0.40%)
Cardiac death, n (%)	3 (0.30%)	4 (0.40%)	4 (0.40%)
Non-cardiac death, n (%)	0 (0%)	0 (0%)	0 (0%)
Myocardial infarction, n (%)	0 (0%)	7 (0.70%)	10 (1.0%)
Q-wave, n (%)	0 (0%)	3 (0.30%)	4 (0.40%)
Non Q-wave, n (%)	0 (0%)	4 (0.40%)	6 (0.60%)
TLR, n (%)	0 (0%)	5 (0.50%)	6 (0.60%)
TVR, n (%)	0 (0%)	0 (0%)	0 (0%)
ST, n (%)	0 (0%)	2 (0.20%)	2 (0.20%)
Definite, n (%)	0 (0%)	0 (0%)	0 (0%)
Probable, n (%)	0 (0%)	2 (0.20%)	2 (0.20%)
Total MACE	3 (0.30%)	18 (1.80%)	22 (2.20%)

TVR - target vessel revascularization; TLR - target lesion revascularization, ST - stent thrombosis